Introduction:

The Metabolic Syndrome (MS) is an epidemic and a public health problem, due to the growing prevalence of obesity and unhealthy lifestyles. It is associated with a 5-fold increase in the risk of Diabetes Mellitus type 2, and a 2 to 3-fold increase in the risk of cardiovascular disease, with a decrease in survival. After menopause, the prevalence of MS increases even more, generating a very significant increase in cardiovascular risk.

Objectives:

To know the prevalence of MS in patients hospitalized from January to June 2017 in the HC-IPS Gynecology Service and to compare the prevalence of MS obtained according to NCEP ATPIII and IDF criteria in premenopausal and postmenopausal women.

Methodology:

Retrospective, descriptive cross-sectional study.

Results:

Of 380 patients observed, the average age was 43.77% had a BMI greater than 25. 56.8% were premenopausal and 43.1% postmenopausal. The prevalence of MS was different according to the criteria of NCEP ATPIII and the IDF, being 23.1% with the first and 63% with the second. It was found that 80% of premenopausal and 90% of postmenopausal women had a BMI greater than 25. The gynecological pathology most associated was endometrial thickening, observed in 18% of cases of MS in postmenopausal women. In premenopausal women it was observed that in 40% the MS was related to HUA and uterine myomatosis. The percentage of endometrial cancer was quite important being 11%.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )